Bioengineer Gang Bao uses gene editing to repair up to 40 percent of bone marrow cells from patients
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
Bao’s lab collaborated with Vivien Sheehan, an assistant professor of pediatrics and hematology at Baylor and a member of the sickle cell program at Texas Children’s, to collect stem and progenitor cells (CD34-positive cells) from patients with the disease. These were then edited in the Bao lab with CRISPR/Cas9 together with a custom template, a piece of DNA designed to correct the mutation.
The gene-edited cells were injected into the bone marrow of immunodeficient mice and tested after 19 weeks to see how many retained the edit. “The rate of repair remained stable, which is great,” Bao said. This engraftment study was carried out in the lab of Matt Porteus, an associate professor of pediatrics at Stanford.
Another major finding of the study is that the CRISPR/Cas9 system could introduce large alterations to the genes in patients’ cells, in addition to small mutations or deletions. These off-target effects could cause a disease.
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
The Latest on: Sickle cell disease
via Google News
The Latest on: Sickle cell disease
- Can a drug turn back the clock in sickle cell disease?on April 13, 2021 at 8:20 am
A new drug for sickle cell disease appears to be effective in a mouse model of the condition. Now, a new study concludes that the drug is safe for humans.
- Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patientson April 12, 2021 at 12:20 pm
population in sickle cell disease (SCD) patients. Current ektacytometry techniques implement laser diffraction viscometry to estimate the RBC deformability in a whole blood sample. However, the ...
- Training program may help children with sickle cell diseaseon April 11, 2021 at 4:36 am
Washington [US], April 11 (ANI): The findings of a recent study suggest that an adaptive cognitive training program could help treat attention and working memory difficulties in children with sickle ...
- Toward a transformative therapy for sickle cell patientson April 9, 2021 at 5:43 pm
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a ...
- Mum launches charity to provide mental health support for people with sickle cellon April 9, 2021 at 8:26 am
Sickle cell disease is an inherited blood condition which predominantly affects people from African and Caribbean backgrounds. People with this illness fall into the ‘extremely vulnerable ...
- Sickle cell disease: scientists are developing a game-changing treatmenton April 9, 2021 at 3:01 am
While other treatments are aimed at the symptoms of sickle cell disease, a new revolutionary drug may target its root.
- Toward a reliable oral treatment for sickle cell diseaseon April 8, 2021 at 9:00 pm
WASHINGTON, April 9, 2021 -- For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or ...
- Death of sickle cell disease patient who rang 999 from hospital bed could have been prevented, coroner sayson April 8, 2021 at 3:15 am
A patient suffering sickle cell crisis who rang 999 from his hospital bed after being refused oxygen would not have died if medics had recognised his symptoms and given him a blood transfusion quicker ...
- Patient, 21, who rang 999 from his NHS hallway hospital bed because he was so desperate to get treatment died because staff did not understand sickle cell disease, inquest hearson April 7, 2021 at 8:36 am
Evan Smith was admitted to North Middlesex hospital with sepsis which triggered a sickle cell crisis in 2019. An inquest heard if he had been given a transfusion earlier he may have survived.
- CRISPR Therapeutics's Leading Thalassemia And Sickle Cell Disease Investigational Therapyon April 6, 2021 at 7:35 am
CRSP's leading investigational therapy CTX001's mode of action creates a situation where the company is killing two birds with one stone, treating both beta-thalassemia and sickle cell disease ...
via Bing News